Skip to content
CIRI-IT
  • HOME_
  • Organization
    • The Origins
    • The Scientific Committee
    • The Center’s Objectives
    • Future Perspectives
  • Research
    • Study on RSV epidemiology and impact: RESPIRA 50
    • RSV ComNet Project
    • EPSS Studies
    • ID.DRIVE
  • Publications
  • News_
    • Nirsevimab: a new opportunity for RSV prevention in Newborns
    • Sexually transmitted diseases
    • Prevention and control of Influenza – 2024–2025 Season
  • Contacts
    • Newsletter
  • NVPP 2023–2025
  • Italiano
  • English
  • Toggle website search
Search this website
Menu Close
  • HOME_
  • Organization
    • The Origins
    • The Scientific Committee
    • The Center’s Objectives
    • Future Perspectives
  • Research
    • Study on RSV epidemiology and impact: RESPIRA 50
    • RSV ComNet Project
    • EPSS Studies
    • ID.DRIVE
  • Publications
  • News_
    • Nirsevimab: a new opportunity for RSV prevention in Newborns
    • Sexually transmitted diseases
    • Prevention and control of Influenza – 2024–2025 Season
  • Contacts
    • Newsletter
  • NVPP 2023–2025
  • Italiano
  • English
  • Toggle website search
Read more about the article Avian Influenza and the New mRNA Vaccine

Avian Influenza and the New mRNA Vaccine

Avian influenza, particularly the H5N1 strain, continues to pose a serious threat to global public health. This virus, while primarily…

Continue ReadingAvian Influenza and the New mRNA Vaccine
Read more about the article Antibiotic Resistance: a responsible approach

Antibiotic Resistance: a responsible approach

With the arrival of the autumn and winter seasons, there is a significant increase in respiratory infections such as colds,…

Continue ReadingAntibiotic Resistance: a responsible approach
Read more about the article Respiratory infections, 2024–2025 record season: over 16 million Italians affected

Respiratory infections, 2024–2025 record season: over 16 million Italians affected

Whithin Week 17 of 2025, the RespiVirNet influenza surveillance system has concluded, marking a record-breaking season. According to the latest…

Continue ReadingRespiratory infections, 2024–2025 record season: over 16 million Italians affected
Read more about the article First Italian real-world results on the tolerability of the adjuvanted RSV vaccine in adults aged 60 and over published in Vaccine: X

First Italian real-world results on the tolerability of the adjuvanted RSV vaccine in adults aged 60 and over published in Vaccine: X

The study titled “Enhanced safety surveillance of the adjuvanted respiratory syncytial virus vaccine among Italian older adults” was recently published…

Continue ReadingFirst Italian real-world results on the tolerability of the adjuvanted RSV vaccine in adults aged 60 and over published in Vaccine: X
← Newer Posts
Older Posts →

Search

CM_EN

  • HOME_
  • Organization
    • The Origins
    • The Scientific Committee
    • The Center’s Objectives
    • Future Perspectives
  • Research
    • Study on RSV epidemiology and impact: RESPIRA 50
    • RSV ComNet Project
    • EPSS Studies
    • ID.DRIVE
  • Publications
  • News_
    • Nirsevimab: a new opportunity for RSV prevention in Newborns
    • Sexually transmitted diseases
    • Prevention and control of Influenza – 2024–2025 Season
  • Contacts
    • Newsletter
  • NVPP 2023–2025
  • Italiano
  • English

Restricted Area

  • Accesso
  • DISSAL
  • UNIGE
© Copyright 2023 - CIRI-IT InterUniversity Research Center on Influenza

SPECIALE COVID-19

Lorem ipsum dolor sit amet, consectetur adipiscing elit. In pulvinar erat ut venenatis maximus. Duis varius fermentum imperdiet. Morbi ipsum odio, ultricies non diam et, consectetur auctor lacus. Nunc a mi tellus. Nullam sit amet urna imperdiet, malesuada enim et, rutrum libero. Donec vel orci quis felis dapibus lobortis et at diam. Suspendisse at vehicula risus, maximus pretium dolor. Duis congue dolor nec ante dapibus, et venenatis libero finibus. Donec in mattis est. Morbi euismod, metus at lobortis rhoncus, lacus arcu malesuada lectus, sed pharetra magna diam ut purus. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Integer quis lorem vulputate, elementum lacus non, porta ipsum.